Lista de obras -

A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations

artículo científico publicado en 2020

A method for identification of HIV gp140 binding memory B cells in human blood

artículo científico publicado en 2008

A single cycle of rituximab for the treatment of severe pemphigus.

artículo científico publicado en 2007

AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges

artículo científico publicado en 2015

Amplification of highly mutated human Ig lambda light chains from an HIV-1 infected patient

artículo científico publicado en 2015

Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity

artículo científico publicado en 2010

Antibodies in HIV-1 vaccine development and therapy

artículo científico publicado en 2013

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

artículo científico publicado en 2017

Antibody B cell responses in HIV-1 infection

artículo científico

Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

artículo científico publicado en 2013

Binding mechanisms of therapeutic antibodies to human CD20

artículo científico publicado en 2020

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

artículo científico publicado en 2009

Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein

artículo científico publicado en 2012

Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission

artículo científico publicado en 2013

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

artículo científico publicado en 2021

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

artículo científico publicado en 2012

Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity.

artículo científico publicado en 2018

Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cells

artículo científico publicado en 2011

Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice

artículo científico publicado en 2012

ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.

artículo científico publicado en 2009

Early Antiretroviral Therapy Preserves Functional Follicular Helper T and HIV-Specific B Cells in the Gut Mucosa of HIV-1-Infected Individuals.

artículo científico publicado en 2018

Efficient generation of human IgA monoclonal antibodies

artículo científico publicado en 2015

Elimination of HIV-1-infected cells by broadly neutralizing antibodies

artículo científico publicado en 2016

Enhanced HIV-1 neutralization by antibody heteroligation

artículo científico publicado en 2012

Feedback control of regulatory T cell homeostasis by dendritic cells in vivo

artículo científico publicado en 2009

Genetic factors in pemphigus

artículo científico publicado en 2005

Genetically intact but functionally impaired HIV-1 Env glycoproteins in the T-cell reservoir.

artículo científico publicado en 2017

HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies.

artículo científico publicado en 2014

HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.

scientific article published on 24 October 2012

HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells

article

HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice

artículo científico publicado en 2013

HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection

artículo científico publicado en 2017

HIV: Roadmaps to a vaccine

artículo científico publicado en 2013

Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness

artículo científico publicado en 2010

Humanized mouse models to study pathophysiology and treatment of HIV infection

artículo científico publicado en 2017

Hunting Down the HIV-1 Reservoir: A Starring Role for Antibodies?

artículo científico publicado en 2017

Immunogenetics of pemphigus: an update

artículo científico publicado en 2006

Impact of Antigen Density on the Binding Mechanism of IgG Antibodies

artículo científico publicado en 2017

Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies

artículo científico publicado en 2017

Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses

artículo científico publicado en 2011

Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas

artículo científico publicado en 2015

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

artículo científico publicado en 2014

Polyreactive antibodies in adaptive immune responses to viruses

artículo científico publicado en 2011

Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation

artículo científico publicado en 2010

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

artículo científico publicado en 2021

Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals

artículo científico publicado en 2021

Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity

artículo científico publicado en 2017

SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors.

artículo científico publicado en 2020

Scarcity of autoreactive human blood IgA+ memory B cells

artículo científico publicado en 2016

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

artículo científico publicado en 2011

Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

artículo científico publicado en 2013

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

scientific article published on 12 May 2022

TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice

artículo científico publicado en 2020

Tailored immunogens for rationally designed antibody-based HIV-1 vaccines

artículo científico publicado en 2015

The value of open-source clinical science in pandemic response: lessons from ISARIC

artículo científico publicado en 2021

V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1

artículo científico publicado en 2015

What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Lessons from the Antibody Response to HIV-1.

artículo científico publicado en 2017

[CRISPR-Cas9 editing of HIV-1 neutralizing human B cells]

scientific article published on 01 December 2019

Lista de obras de

A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations

A method for identification of HIV gp140 binding memory B cells in human blood

A single cycle of rituximab for the treatment of severe pemphigus.

AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges

Amplification of highly mutated human Ig lambda light chains from an HIV-1 infected patient

Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity

Antibodies in HIV-1 vaccine development and therapy

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Antibody B cell responses in HIV-1 infection

Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

Binding mechanisms of therapeutic antibodies to human CD20

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein

Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity.

Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cells

Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice

ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.

Early Antiretroviral Therapy Preserves Functional Follicular Helper T and HIV-Specific B Cells in the Gut Mucosa of HIV-1-Infected Individuals.

Efficient generation of human IgA monoclonal antibodies

Elimination of HIV-1-infected cells by broadly neutralizing antibodies

Enhanced HIV-1 neutralization by antibody heteroligation

Feedback control of regulatory T cell homeostasis by dendritic cells in vivo

Genetic factors in pemphigus

Genetically intact but functionally impaired HIV-1 Env glycoproteins in the T-cell reservoir.

HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies.

HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.

HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells

HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice

HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection

HIV: Roadmaps to a vaccine

Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness

Humanized mouse models to study pathophysiology and treatment of HIV infection

Hunting Down the HIV-1 Reservoir: A Starring Role for Antibodies?

Immunogenetics of pemphigus: an update

Impact of Antigen Density on the Binding Mechanism of IgG Antibodies

Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies

Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses

Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

Polyreactive antibodies in adaptive immune responses to viruses

Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals

Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity

SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors.

Scarcity of autoreactive human blood IgA+ memory B cells

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice

Tailored immunogens for rationally designed antibody-based HIV-1 vaccines

The value of open-source clinical science in pandemic response: lessons from ISARIC

V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1

What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Lessons from the Antibody Response to HIV-1.

[CRISPR-Cas9 editing of HIV-1 neutralizing human B cells]